Literature DB >> 10202060

Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis.

K G Yeoh1, M J Zimmerman, J T Cunningham, P B Cotton.   

Abstract

BACKGROUND: For palliation of patients with malignant obstructive jaundice, expansile metal stents provide longer patency than plastic stents but are more expensive. The optimal cost-effective strategy has not been established. Our aim was to compare the relative costs of 3 strategies: (1) plastic stent, with exchange on occlusion; (2) metal stent initially, with coaxial plastic stent insertion in the event of occlusion; or (3) plastic stent initially, with metal stent exchange in the event of occlusion.
METHODS: A decision analysis model was created using DATA 2.6 software to assess the relative costs of the three strategies. Values for variables including the probabilities of reintervention and patient survival were obtained from published data. Costs were based on Medicare reimbursements of hospital charges, and the model was evaluated from the perspective of a third-party payer. One-way and two-way sensitivity analysis of the variables was performed over a wide range.
RESULTS: The outcome is highly sensitive to the ratio of metal stent cost relative to endoscopic retrograde cholangiopancreatography cost (cost ratio M:ERCP) and to the length of survival of the patient. The most economical strategies were (2), (3) and (1) for M:ERCP cost ratios of <0.5, 0.5 to 0.7, and >0.7, respectively.
CONCLUSIONS: The choice of stent should be guided by the relative local costs of ERCP and metal stents and by the prognosis of the patient. At current metal stent costs and Medicare reimbursement rates, initial placement of a plastic stent, followed by metal stent placement at first occlusion in longer survivors, is an economical option. If metal stent cost is less than half of ERCP cost, then initial insertion of a metal stent would be most economical. Use of plastic stents is preferable for patients surviving less than 4 months, whereas metal stents are more economical for patients with longer survival.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202060     DOI: 10.1016/s0016-5107(99)70044-1

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  45 in total

1.  Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma.

Authors:  R C G Martin; G C Vitale; D N Reed; G M Larson; M J Edwards; K M McMasters
Journal:  Surg Endosc       Date:  2002-01-09       Impact factor: 4.584

2.  Is the use of T-tube necessary after laparoscopic choledochotomy?

Authors:  Ahmed Abdel-Raouf El-Geidie
Journal:  J Gastrointest Surg       Date:  2010-03-16       Impact factor: 3.452

3.  Endoscopic management of occluded metal biliary stents: metal versus 10F plastic stents.

Authors:  Won Jae Yoon; Ji Kon Ryu; Jung Won Lee; Dong-Won Ahn; Yong-Tae Kim; Yong Bum Yoon; Sang Myung Woo; Woo Jin Lee
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

4.  Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents.

Authors:  Peter L Moses; Khalid M Alnaamani; Alan N Barkun; Stuart R Gordon; Roger D Mitty; M Stanley Branch; Thomas E Kowalski; Myriam Martel; Viviane Adam
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

5.  Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction.

Authors:  Yoshimi Iwasaki; Mitsuru Ishizuka; Masato Kato; Junji Kita; Mitsugi Shimoda; Keiichi Kubota
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

6.  Combined percutaneous-endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome.

Authors:  C P Neal; S C Thomasset; D Bools; C D Sutton; G Garcea; C D Mann; Y Rees; C Newland; R J Robinson; A R Dennison; D P Berry
Journal:  Surg Endosc       Date:  2009-06-30       Impact factor: 4.584

7.  Multicenter study evaluating factors for stent patency in patients with malignant biliary strictures: development of a simple score model.

Authors:  Petra G A van Boeckel; Ewout W Steyerberg; Frank P Vleggaar; Marcel J M Groenen; Ben J M Witteman; Bas L A M Weusten; Han Geldof; Adriaan C I T L Tan; Marina J A L Grubben; Jan Nicolai; Peter D Siersema
Journal:  J Gastroenterol       Date:  2011-07-14       Impact factor: 7.527

Review 8.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

9.  Metal stents: a bridge to surgery in hilar cholangiocarcinoma.

Authors:  Dirk J Grünhagen; Declan F J Dunne; Richard P Sturgess; Nick Stern; Stephen Hood; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  HPB (Oxford)       Date:  2012-10-16       Impact factor: 3.647

10.  Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma.

Authors:  Jaap J Kloek; Niels A van der Gaag; Yalda Aziz; Erik A J Rauws; Otto M van Delden; Johan S Lameris; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  J Gastrointest Surg       Date:  2009-09-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.